Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Inventory: 2022-2024

Historic Inventory for Arcutis Biotherapeutics (ARQT) over the last 3 years, with Dec 2024 value amounting to $14.5 million.

  • Arcutis Biotherapeutics' Inventory rose 59.96% to $22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.4 million, marking a year-over-year increase of 59.96%. This contributed to the annual value of $14.5 million for FY2024, which is 10.60% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Inventory stood at $14.5 million for FY2024, which was up 10.60% from $13.1 million recorded in FY2023.
  • Arcutis Biotherapeutics' Inventory's 5-year high stood at $14.5 million during FY2024, with a 5-year trough of $7.5 million in FY2022.
  • Its 3-year average for Inventory is $11.7 million, with a median of $13.1 million in 2023.
  • Data for Arcutis Biotherapeutics' Inventory shows a peak YoY soared of 74.79% (in 2023) over the last 5 years.
  • Over the past 3 years, Arcutis Biotherapeutics' Inventory (Yearly) stood at $7.5 million in 2022, then surged by 74.79% to $13.1 million in 2023, then climbed by 10.60% to $14.5 million in 2024.